Eli Lilly surged 58% in 2024, driven by weight-loss drugs and strong earnings. The technical chart shows consolidation. See ...

The Leadership Team extends our deepest ... welcomed a new partnership with Eli Lilly and Company. We also thank Lockheed Martin for being our steadfast partner for over a decade. Louise is an ...

This is thanks to Lilly's dominance in the billion-dollar weight loss drug market. Lilly's Mounjaro and Zepbound have helped ...

Discover Citi's bullish outlook on Eli Lilly with a $1,060 target. Is now the time to invest? Find key insights and price ...

In fact, demand has been so high that it's been surpassing supply, forcing Lilly and rival Novo Nordisk to invest in ...

Mounjaro and its cast of supporters are surprising everyone, even (so it seems) the company's management ... investing in Eli Lilly. The Motley Fool Stock Advisor analyst team just identified ...

Amazon will now deliver pharmaceutical giant Eli ... management, customers will be able to get the medications to their door with ongoing tracking updates and access to customer care teams. Both ...

Eli Lilly is unveiling LillyDirect, a new digital healthcare platform for patients living with obesity, migraine and diabetes. LillyDirect offers disease management resources, including access to ...

GC Therapeutics has entered gameplay with the mission of unlocking a new generation of cell therapies, uploading with $75 ...

At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...

The idea is management is confident ... Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Eli Lilly wasn’t one of them.